ProQuest Management LLC, 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 13,159 shares at $14.50 ($148K) on 2007-08-20, disclosed to the SEC on 2007-08-22.
Open-market sale of $148k CADX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.50 | 200 | $3K | 2.0% |
| 2 | $14.51 | 300 | $4K | 2.9% |
| 3 | $14.53 | 125 | $2K | 1.2% |
| 4 | $14.53 | 75 | $1K | 0.7% |
| 5 | $14.54 | 111 | $2K | 1.1% |
| 6 | $14.55 | 389 |
| $6K |
| 3.8% |
| 7 | $14.61 | 100 | $1K | 1.0% |
| 8 | $14.62 | 100 | $1K | 1.0% |
| 9 | $14.64 | 400 | $6K | 4.0% |
| 10 | $14.65 | 314 | $5K | 3.1% |
| 11 | $14.66 | 50 | $733 | 0.5% |
| 12 | $14.67 | 786 | $12K | 7.8% |
| 13 | $14.68 | 262 | $4K | 2.6% |
| 14 | $14.69 | 300 | $4K | 3.0% |
| 15 | $14.70 | 438 | $6K | 4.4% |
| 16 | $14.71 | 1,026 | $15K | 10.2% |
| 17 | $14.72 | 800 | $12K | 8.0% |
| 18 | $14.73 | 100 | $1K | 1.0% |
| 19 | $14.74 | 124 | $2K | 1.2% |
| 20 | $14.81 | 100 | $1K | 1.0% |
| 21 | $0.40 | 3,125 | $1K | 0.8% |
| 22 | $14.50 | 2,822 | $41K | 27.7% |
| 23 | $14.52 | 12 | $174 | 0.1% |
| 24 | $14.54 | 100 | $1K | 1.0% |
| 25 | $14.59 | 100 | $1K | 1.0% |
| 26 | $14.67 | 900 | $13K | 8.9% |
| Total | $11.24 avg | 13,159 | $148K | 100% |